Burning Rock Biotech Ltd.-ADRBNR
13F holders, Q3 2025 (September 30)16holders −1
2new positions
3sold out
1famous investor
$8.68avg. 13F price*
At the end of Q3 2025, 16 institutions reported holding Burning Rock Biotech Ltd.-ADR (BNR) in their 13F filings, down 1 from Q2 2025. 2 opened new positions and 3 sold out. The largest holders were Kynam Capital Management, LP ($8.6M), CRCM LP ($1.9M) and Amova Asset Management Americas, Inc. ($314K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Burning Rock Biotech Ltd.-ADR
- CUSIP
- 12233L206
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $240K |
| Exits | 3 | $175K |
All 13F filers, Q2 2025 → Q3 2025: 58,796 shares bought and 73,560 shares sold, net −14,764 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| Kynam Capital Management, LP | 0.64% | No change | 994,883 | $8.6M |
| CRCM LP | 0.56% | Add +13.8% | 221,575 | $1.9M |
| Amova Asset Management Americas, Inc. | 0.00% | Reduce -20.7% | 34,842 | $314K |
| Sumitomo Mitsui Trust Group, Inc. | 0.00% | Reduce -20.7% | 34,842 | $301K |
| Renaissance Technologies | 0.00% | No change | 31,717 | $274K |
| Bank of America Corp. | 0.00% | Reduce -0.3% | 29,178 | $252K |
| HSG Holding Ltd | 0.01% | No change | 21,212 | $215K |
| Prospera Financial Services Inc | 0.00% | New | 24,755 | $214K |
| Morgan Stanley | 0.00% | Add +22.3% | 22,267 | $193K |
| SkyView Investment Advisors, LLC | 0.01% | No change | 10,000 | $87K |
| China Universal Asset Management Co., Ltd. | 0.00% | New | 3,000 | $26K |
| Shen Neil Nanpeng | 10.15% | No change | 885 | $9K |
| BNP Paribas Financial Markets | 0.00% | No change | 900 | $8K |
| UBS Group AG | 0.00% | Add +22.4% | 868 | $8K |
| JPMorgan Chase & Co. | 0.00% | Add +25.5% | 64 | $554 |
| BlackRock, Inc. | 0.00% | No change | 10 | $87 |
"% of holder's portfolio" is BNR's weight in each manager's 13F, not the share of Burning Rock Biotech Ltd.-ADR the manager owns.